Last week, researchers found that cannabis and psychedelic medicines are able to improve the effectiveness of breast cancer treatments. In addition to the usual benefits of improved mental health and pain relief from cannabis, researchers also found increases in the body’s innate cancer-fighting mechanisms. Unfortunately, the stigmatization of cannabis and psychedelics still hinders progress.
According to new research, cannabis- and psychedelic-based drugs combined with conventional treatments may be effective against breast cancer.
This is just the latest in a growing body of research demonstrating the effectiveness of cannabis in the fight against all manner of illnesses. To keep up with what’s next, download our free cannabis news app.
First Study on Breast Cancer Patients
On Friday, Grace Health & Wellness (GHW) revealed the results of a new study published in SAGE Journals, which documented the use of these alternative treatments in breast cancer patients for the first time.
According to GHW, a 49-year-old woman was diagnosed with breast cancer in 2018 and underwent a series of conventional therapies in combination with psilocybin mushrooms and cannabis foods. This unconventional combination of therapies improved the overall effectiveness of the treatment.
Cannabis Improves the Lives of Breast Cancer Patients
“We work with breast cancer patients, intervening with cannabis and psilocybin. They are invaluable, and their impact is enormous,” said Dr. Dustin Sulak, a doctor of osteopathic medicine and medical cannabis expert.
“They can improve a patient’s quality of life, relieving pain, depression, and anxiety while providing psychological adaptation to a difficult diagnosis and prognosis. They can also enhance our innate anti-cancer mechanisms and work additively or synergistically with other treatments.”
Cannabis and Psilocybin in Breast Cancer Treatment
A new study suggests that a patient’s use of psychedelics and cannabinoids improved the results of traditional breast cancer treatments such as Herceptin, Taxotere (a chemotherapy drug), and Perjeta.
“Based on my clinical experience, all breast cancer patients can benefit in some way from the appropriate use of cannabis and psilocybin,” Dr. Sulak added.
“They will also be the standard in the future, as both have a high safety profile. While the research community focuses on therapeutic effects for treating psychiatric conditions, Nicole’s case shows that they affect physical conditions such as breast cancer.”
GHW also states that new research suggests a link between cannabis, psychedelics, reduced inflammation in the body, improved mental health, and better breast cancer management.
Stigmatization of Cannabis and Psilocybin Hinders Research Progress
The researchers agreed that the stigmatization of cannabis and psilocybin was one of the obstacles to scientific research. The substances are illegal in many countries, but the situation continues to improve worldwide as more attention is given to their medicinal properties.
“Cannabis and psilocybin saved my life because I was able to eat, sleep and function, and the nausea was almost non-existent.” – said Nicole Di Monda, a breast cancer patient participating in the study.
These plant-derived drugs were administered by Nicole’s husband, Jaime Brambila, an endocannabinoid scientist who is also co-founder and scientific director of GHW.
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published by Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.